Development of CNS metastases in breast cancer patients treated with curative intent: a case–control study

Background: The aim of this study was to identify risk factors that may predispose breast cancer patients to the development of CNS metastases. Materials & methods: We conducted a matched case–control study of breast cancer patients treated with surgery with curative intent. A total of 71 cases...

Full description

Saved in:
Bibliographic Details
Main Authors: Katherine Chakrabarti, Leigh K Swartz, Anoop Gill, Fang Fang, Kelley M Kidwell, Aki Morikawa
Format: Article
Language:English
Published: Taylor & Francis Group 2020-09-01
Series:CNS Oncology
Subjects:
Online Access:https://www.futuremedicine.com/doi/10.2217/cns-2020-0012
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: The aim of this study was to identify risk factors that may predispose breast cancer patients to the development of CNS metastases. Materials & methods: We conducted a matched case–control study of breast cancer patients treated with surgery with curative intent. A total of 71 cases and 71 controls were analyzed, matched by year of surgery. Results: In our multivariable model, positive lymph node status (odds ratio [OR]: 5.08; CI: 2.04–12.65), the use of neoadjuvant chemotherapy (OR: 6.02; CI: 2.06–17.57) and triple-negative breast cancer (OR: 5.44; CI: 1.99–14.90) were statistically significant predictors of the development of CNS metastases. Conclusion: Women with certain risk factors have an increased odds of developing CNS metastases and evaluation of utility in brain metastases screening should be considered.
ISSN:2045-0907
2045-0915